Array BioPharma (ARRY) MEK Deal 'Favorable', BMO Capital Says

Go back to Array BioPharma (ARRY) MEK Deal 'Favorable', BMO Capital Says
Array Biopharma, Inc. (NASDAQ: ARRY) Delayed: 5.06 -0.02 (0.39%)
Previous Close $5.08    52 Week High $7.27 
Open $5.06    52 Week Low $2.39 
Day High $5.06    P/E N/A 
Day Low $5.06    EPS $-0.61 
Volume 1,033